Inge

Inge Andersson, Smalandsstenar SE

Patent application number	Description	Published
20090175674	Device at a Binder - A device for fastening prongs in binders, where the prongs are secured to a prong plate arranged to be fastened to the inner sections of a binder spine. Fastening mechanisms are arranged in rows along the binder spine sections. The fastening mechanisms are releasably connectable to supplementary fastening devices located on the respective prong plates. A device for fastening binder sides is also disclosed.	07-09-2009

Inge Bruheim, Volda NO

Patent application number	Description	Published
20080274203	BIOEFFECTIVE KRILL OIL COMPOSITIONS - This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO	11-06-2008
20100316680	ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS - Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.	12-16-2010
20110104297	METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS - This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondrial respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.	05-05-2011
20110288165	NOVEL LIPID COMPOSITION FOR THE TREATMENT OF SKIN PROBLEMS IN COMPANION ANIMALS - The present invention provides lipid compositions comprising linolenic acid (LA), alpha-linolenic acid (ALA), stearidonic acid (SDA) and gamma linolenic acid (GLA), said LA and ALA in a ratio of about less than 2:1 LA:ALA. The compositions find use in for improving, treating, or preventing a condition selected from the group consisting of: eczema, dry skin, flaky skin, pruritus, pyotraumatic dermatitis, furunculosis, dry paw pads, rough paw pads, chapped paw pads, paw pad durability, dry rhinarium, chapped rhinarium, split claws, brittle claws, rashes, hairless spots, hot spots, symmetrical lupoid onychodystrophy, skin ulceration, skin crusting, reddening of skin between toes, external ear infection, and nutritional dermatosis.	11-24-2011
20120149867	Method For Processing Crustaceans And Products Thereof - The present invention contemplates the creation of a low fluoride oil processed from a phospholipid-protein complex (PPC) formed immediately upon a crustacean (i.e., for example, krill) catch. The process comprises disintegrating the crustaceans into smaller particles, adding water, heating the result, adding enzyme(s) to hydrolyze the disintegrated material, deactivating the enzyme(s), removing solids from the enzymatically processed material to reduce fluoride content of the material, separating and drying the PPC material. Then, using extraction with supercritical CO	06-14-2012
20120231087	Compositions And Methods for Nutritional Supplementation - The present invention relates to nutritional supplement compositions comprising krill meal and lipid insoluble ingredients. The compositions can be used to provide supplementary nutrition to humans or animals. The present invention relates also formulations, such as tablets, which are easy to administer to animals. It is also shown that krill meal added to animal food at low levels will improve the palatability of the product.	09-13-2012
20130225794	REDUCED FLUORIDE CRUSTACEAN OIL COMPOSITIONS - The present invention contemplates the creation of a low fluoride oil processed from a phospholipid-protein complex (PPC) formed immediately upon a crustacean (i.e., for example, krill) catch. The process comprises disintegrating the crustaceans into smaller particles, adding water, heating the result, adding enzyme(s) to hydrolyze the disintegrated material, deactivating the enzyme(s), removing solids from the enzymatically processed material to reduce fluoride content of the material, separating and drying the PPC material. Then, using extraction with supercritical CO	08-29-2013
20140005421	BIOEFFECTIVE KRILL OIL COMPOSITIONS	01-02-2014
20140249227	LIPID COMPOSITION FOR THE PREVENTION OR TREATMENT OF SKIN PROBLEMS - The invention relates to a novel lipid composition. Further, the invention relates to the use of a lipid composition for the treatment, alleviation and prevention of skin problems.	09-04-2014
20140363517	METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS - This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.	12-11-2014
20150030751	Method for Processing Crustaceans to Produce Low Fluoride/Low Trimethyl Amine Products Thereof - The present invention contemplates the creation of a low fluoride crustacean oil processed from a phospholipid-protein complex (PPC) formed immediately upon a crustacean (i.e., for example, krill) catch. Further, the crustacean oil may also have reduced trimethyl amine and/or trimethyl amino oxide content. The process comprises disintegrating the crustaceans into smaller particles, adding water, heating the result, adding enzyme(s) to hydrolyze the disintegrated material, deactivating the enzyme(s), removing solids from the enzymatically processed material to reduce fluoride content of the material, separating and drying the PPC material. Then, using extraction with supercritical CO	01-29-2015
20150157669	BIOEFFECTIVE KRILL OIL COMPOSITIONS - This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO	06-11-2015
20150272164	Reduced Flouride Crustacean De-Oiled Protein-Phospholipid Complex Compositions - The present invention contemplates the creation of a low fluoride oil processed from a phospholipid-protein complex (PPC) formed immediately upon a crustacean (i.e., for example, krill) catch. The process comprises disintegrating the crustaceans into smaller particles, adding water, heating the result, adding enzyme(s) to hydrolyze the disintegrated material, deactivating the enzyme(s), removing solids from the enzymatically processed material to reduce fluoride content of the material, separating and drying the PPC material. Then, using extraction with supercritical CO	10-01-2015
20160095888	METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS - This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.	04-07-2016

Inge Dierynck, Berchem BE

Patent application number	Description	Published
20090118339	LYSINE RELATED DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS - The present invention concerns lysine related derivatives, their use as protease inhibitors, in particular as HIV aspartyl protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present lysine related derivatives with another anti retroviral agent. It further relates to their use in assays as reference compounds or as reagents.	05-07-2009
20090209583	2-(SUBSTITUTED-AMINO)-BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS - The present invention relates to 2-(substituted-amino)-benzothiazole sulfonamide compounds and derivatives, their use as protease inhibitors, in particular as broad-spectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present 2-(substituted-amino)-benzothiazole sulfonamide compounds and derivatives with another anti-retroviral agent. It further relates to their use in assays as reference compounds or as reagents.	08-20-2009
20100173282	MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e. correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management.	07-08-2010
20100173381	CRYSTAL STRUCTURES OF HIV-1 PROTEASE INHIBITORS BOUND TO HIV-1 PROTEASE - Described herein are methods for rational design of inhibitors of HIV-1 protease, and crystal structures of HIV-1 protease inhibitors bound to HIV-1 protease.	07-08-2010
20120258448	MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management.	10-11-2012
20140127797	MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The invention concerns novel mutations or mutational profiles of HIV-1 protease cleavage sites (CS) in the Gag region correlated with a phenotype causing alterations in sensitivity to anti-HIV drugs. The present invention also relates to the use of genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention further relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design and clinical management.	05-08-2014

Inge Fadnes, Bergen NO

Patent application number	Description	Published
20140193282	Drilling Fluid Pump Module Coupled to Specially Configured Riser Segment and Method for Coupling the Pump Module to the Riser - A pump module for a drilling riser includes at least one pump mounted to a frame, the frame including features to couple the frame to a segment of riser. A fluid inlet is affixed to the frame. The fluid inlet is in fluid communication with an intake of the at least one pump. The fluid inlet has features to make fluid tight hydraulic connection to a fluid outlet of the riser segment when the frame is coupled thereto.	07-10-2014

Inge Gabrielii, Kallered SE

Patent application number	Description	Published
20140130956	METHOD OF FORMING AN ELASTIC LAMINATE - A method of forming an elastic laminate including at least one elastic film and least two nonwoven webs laminated to each of the sides of the elastic film. The elastic film is fed in a machine direction towards a bonding station. The elastic film is stretched in the machine direction at a stretch ratio from 1.5 to 8 times of its original length, thereby forming a stretched film and the stretched film and said at least two nonwoven webs are laminated in the bonding station. The elastic film is stretched in at least two stretching steps before laminating it with the at least two nonwoven webs, wherein between 5 and 25% of the total stretching occurs in the last stretching step before lamination in the bonding station.	05-15-2014
20150328056	ELASTIC LAMINATE AND PROCESS FOR THE MANUFACTURE OF ELASTIC LAMINATE - An elastic laminate including a first nonwoven layer, a second nonwoven layer, and a plurality of elastic strands arranged in parallel with one another between said first and second nonwoven layers is disclosed, as well as a process for the production of the laminate. The elastic laminate includes elastic strands that are stretched and individually coated with an adhesive. The first and second nonwoven layers are attached to the stretched elastic strands to provide a corrugated elastic laminate when the elastic strands are relaxed. At least one of the nonwoven layers is attached to the strands at distinct adhesive bonding points in a repeating predetermined pattern in a lengthwise direction along the strands to form a predetermined corrugation pattern, and the nonwoven layers are substantially free of adhesive, except in the adhesive bonding points where the layers are attached to the elastic strands.	11-19-2015

Inge Gabrielii, Vastra Frolunda SE

Patent application number	Description	Published
20100274208	ABSORBENT ARTICLE WITH VENTILATED TOPSHEET - An absorbent article, such as a diaper, sanitary napkin, incontinence guard or panty liner, including a fluid-permeable nonwoven topsheet located on the wearer-facing side thereof. The nonwoven topsheet includes a plurality of channels arranged side-by-side. The channels are located within the nonwoven topsheet, whereby gas is allowed to pass into, out of and along the channels, thus providing ventilation of the absorbent article.	10-28-2010
20110027568	MULTI-COMPONENT FIBRES - A multi-component fibre includes at least two elongated fibre bodies. A first fibre body consists of a first material including a phase change material and a second fibre body consists of a second material and encloses the first fibre body. The phase change material is non-encapsulated or in raw form and the first material includes a viscosity modifier selected from polyolefines having a density in the range of 890-970 kg/m	02-03-2011
20110213325	DISPOSABLE ABSORBENT ARTICLE COMPRISING A PRINTED TAG - A disposable absorbent article intended to be worn around the waist of a wearer. The article includes a chassis having a front portion, a back portion, and a crotch portion there between, and optionally includes a waistband. A printed tag is arranged on the inner wearer facing side of the chassis in at least one of the front portion, back portion or the waistband. The tag has a Surface roughness or Friction according to Kawabata which differs at least 10% from the Surface roughness or Friction respectively according to Kawabata of the surrounding area of the chassis to which the tag is attached. This enhances the possibilities to localize the tag by the fingertips and thus make it possible for a person with poor eyesight and under bad light conditions to differentiate between the front and back of the article.	09-01-2011
20110313388	DISPOSABLE ABSORBENT ARTICLE COMPRISING A PRINTED TAG - A disposable absorbent article intended to be worn around the waist of a wearer includes a chassis having a front portion, a back portion, and a crotch portion there between, and optionally a waistband. A printed tag is arranged on the inner wearer facing side of the chassis in at least one of the front portion, back portion, and the waistband. The tag has at least one first area which is fixedly attached to the chassis and at least one second area which is unattached. The first fixedly attached area covers an area of at least 5% of the total area of the tag and the second unattached area has a length extending along a side edge of the tag of at least 5 mm and a width of at least 1 mm. The tag as described makes it easier to differentiate between the front and back of the article.	12-22-2011

Inge Grundke-Iqbal, Staten Island, NY US

Patent application number	Description	Published
20090005459	NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau - Aminocyclohexane and aminoalkylcyclohexane compounds, which are systemically-active as NMDA receptor antagonists, are effective in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau, method of treating disorders resulting from or associated with abnormal hyperphosphorylation of microtubule associated protein tau, and pharmaceutical compositions comprising the same.	01-01-2009
20100029572	Neurotrophic Peptides - The present invention relates to a neurotrophic peptide having an amino acid sequence selected from the group consisting of VG-DGGLFEKKL (SEQ ID No. 1), EDQQVHFTPTEG (SEQ ID No. 2) and IPENEADGMPATV (SEQ ID NO. 3).	02-04-2010
20100273196	System and Method for Evaluating Blood-Neural Barrier Permeability - A system and method for evaluating blood-neural barrier permeability. Phospholipid liposomes are labeled with a fluorescent phospholipase A	10-28-2010
20110160141	Neurotrophic Peptides - The present invention relates to a neurotrophic peptide having an amino acid sequence of VGDGGLFEKKL (SEQ ID NO:1), EDQQVHFTPTEG (SEQ ID NO:2) or IPENEADGMPATV (SEQ ID NO:3), and comprising an adamantyl group at the C- and/or N-terminal end.	06-30-2011
20120157537	NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau - Aminocyclohexane and aminoalkylcyclohexane compounds, which are systemically-active as NMDA receptor antagonists, are effective in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau, method of treating disorders resulting from or associated with abnormal hyperphosphorylation of microtubule associated protein tau, and pharmaceutical compositions comprising the same.	06-21-2012
20130143809	NEUROTROPHIC PEPTIDES - The present invention relates to a neurotrophic peptide having an amino acid sequence of VGDGGLFEKKL (SEQ ID NO:1) and alternatively comprising an adamantyl group at the C- and/or N-terminal end. The neurotrophic peptide can rescue cognition, correct impairments in neural cell proliferation and synaptic plasticity, and thus address the cognitive defects associated with Down syndrome.	06-06-2013
20130157946	NEUROTROPHIC PEPTIDES - The present invention relates to a neurotrophic peptide having an amino acid sequence of VGDGGLFEKKL (SEQ ID NO: 1) and alternatively comprising an adamantyl group at the C- and/or N-terminal end. The neurotrophic peptide can rescue cognition, correct impairments in neural cell proliferation and synaptic plasticity, and thus address the cognitive defects associated with Alzheimer's disease.	06-20-2013
20140018294	NEUROGENIC BRAIN-DERIVED NEUROTROPHIC FACTOR PEPTIDES - Five tetra peptides corresponding to different active regions of brain derived neurotrophic factor (BDNF) that are neurotrophic and can modulate BDNF signaling in a partial agonist/antagonist way. The peptides offer a therapeutic approach to neural pathologies where BDNF levels are dysregulated.	01-16-2014
20140357572	NEUROTROPHIC PEPTIDES FOR THE TREATMENT OF TAUOPATHIES - Peptide 6 and in particular, Peptide 021, may be used to treat tauopathies, such as frontotemporal dementia with Parkinsonism linked to chromosome-17 (FTDP-17) tau, corticobasal degeneration, Pick disease, progressive supranuclear palsy, Guam Parkinsonism dementia complex, dementia pugilistica also known as traumatic encephalopathy or traumatic brain injury, ceroid neuronal lipofusinosis, Hallerworden Sptaz disease, Alzheimer's disease, and adults with Down syndrome.	12-04-2014
20150252087	TREATMENT OF BRAIN INJURY WITH A NEUROTROPHIC PEPTIDE - A neurotrophic peptide having the sequence VGDGGLFEKKL (SEQ ID NO: 1) may be used to help sustain local microenvironment after mild-to-moderate brain injury. Treatment with the peptide was shown to enhance differentiation of newly born progenitors in the dentate gyrus 30 days after injury and to promote neuronal maturation and survival that is not seen naturally after tramautic brain injuries.	09-10-2015
20160102138	TREATMENT OF TAUOPATHIES BY PASSIVE IMMUNIZATION TARGETING THE N-TERMINAL PROJECTION DOMAIN OF TAU - A method of treating tau pathologies, such as Alzheimer's disease, involving the administration of antibodies specific to the amino terminal region of human tau (amino acid residues 6-18 or 184-195) to provide passive immunization. The administration of such antibodies can reduce total tau levels, decrease tau hyperphosphorylation, and improve reference memory. Passive immunization with antibodies targeting the N-terminal projection domain of tau reduces both total and hyperphosphorylated tau was found effective in aged 3×Tg-AD mice, a generally accepted mouse model of Alzheimer's disease and frontotemporal dementia in humans.	04-14-2016

Inge Hjelkrem, Trondheim NO

Patent application number	Description	Published
20090049809	SEPARATOR WITH AXIAL FLOW DEMISTING CYCLONE FOR SEPARATION OF MATERIAL COMPOSITIONS OF GAS, LIQUID AND PARTICULATE SOLIDS - Axial flow demisting cyclone for separation of material compositions of gas, liquid and particulate solids comprising an inlet conduit (	02-26-2009

Inge Karlsson, Nol SE

Patent application number	Description	Published
20160088795	APPARATUS FOR TREATING A CROP - The present disclosure relates to an apparatus (	03-31-2016

Inge Klepsvik, Bergen NO

Patent application number	Description	Published
20140052198	Circuit for Applying Heat and Electrical Stimulation - A circuit (	02-20-2014
20140055239	Configuration of a Stimulation Apparatus - A method for configuring an apparatus (	02-27-2014
20140257429	Stimulation Apparatus - An apparatus (	09-11-2014
20150080989	Moulding Method	03-19-2015
20150190629	Moulded Stimulation Pad	07-09-2015

Inge Klepsvilk, Bergen NO

Patent application number	Description	Published
20140052199	Stimulation Apparatus - An apparatus (	02-20-2014

Inge Knap, Frederiksberg DK

Patent application number	Description	Published
20100247706	BILE RESISTANT BACILLUS COMPOSITION SECRETING HIGH LEVELS OF PHYTASE	09-30-2010
20130071907	BILE RESISTANT BACILLUS COMPOSITION SECRETING HIGH LEVELS OF PHYTASE	03-21-2013

Inge Knap, Farum DK

Patent application number	Description	Published
20100062102	METHOD TO PRODUCE CHICKENS - A method for producing broiler chickens comprising feeding to the chickens a chicken feed comprising from 10	03-11-2010
20110008874	FROZEN LACTIC ACID BACTERIAL CULTURE OF INDIVIDUAL PELLET - A stable, pellet-frozen lactic acid bacteria (LAB) culture comprises at least one additive compound in a commercial relevant package. The pellet-frozen culture has at least 50 g frozen material and a content of viable bacteria of at least 10	01-13-2011
20150223480	STORAGE STABLE FROZEN LACTIC ACID BACTERIA CULTURE - A storage stable frozen lactic acid bacteria (LAB) culture that comprises LAB that are that are able to utilize sucrose, has a weight of at least 50 g frozen material and a content of viable bacteria of at least 10	08-13-2015

Inge Knap, Broenshoej DK

Patent application number	Description	Published
20110189747	PROCESS FOR PRODUCING SILAGE FOR BIOGAS PRODUCTION - The invention provides the use of a lactic acid bacterium and optionally a	08-04-2011
20110262584	BILE RESISTANT BACILLUS COMPOSITION	10-27-2011
20120003351	BILE RESISTANT BACILLUS COMPOSITION SECRETING HIGH LEVELS OF ESSENTIAL AMINO ACIDS	01-05-2012
20130195826	COMPOSITION COMPRISING BACILLUS - The present invention refers to a composition comprising	08-01-2013
20140370146	BILE RESISTANT BACILLUS COMPOSITION	12-18-2014
20150050258	NEMATOCIDAL COMPOSITION COMPRISING BACILLUS SUBTILIS AND BACILLUS LICHENIFORMIS - The present invention refers to a composition comprising	02-19-2015

Inge Knotten, Gursken NO

Patent application number	Description	Published
20100175772	HOSE SYSTEM FOR HIGH PRESSURE HYDRAULIC SYSTEM - Hose system for use in an hydraulic system, includes a working hose for the transfer of hydraulic fluid having a pressure substantially higher than atmospheric pressure, and a safety hose surrounding the working hose, the working hose and the safety hose being tightly joined. A pressure transmitter is arranged for indicating a rise in pressure in a space between the two hoses. The system includes at least one bushing for releasable connection to the working hose and the safety hose. The cross-section of the safety hose allows space for the passing of the end couplings of the working hose. The bushing includes a space communicating with the space between the working hose and the safety hose, the space being in communication with a pressure transmitter able to signal an increase in pressure in the space between the working hose and the safety hose.	07-15-2010
20110210540	HOSE CONNECTOR - Arrangement for a hose system (	09-01-2011

Inge Knotten, Trondheim NO

Patent application number	Description	Published
20100186845	HOSE DEVICE - Device for a hose structure (	07-29-2010

Inge Koch, Belair AU

Patent application number	Description	Published
20140067275	MULTIDIMENSIONAL CLUSTER ANALYSIS - Disclosed is a method of cluster analysis of a data set of multidimensional observations. The method comprises: determining a set of quasi-optimal binwidths for the data set; partitioning, for a current binwidth in the set of quasi-optimal binwidths, the data set into a plurality of bins of width equal to the current binwidth; determining the number of modes of the partitioned data set for the current binwidth; and repeating the partitioning and determining the number of modes for each binwidth in the set of quasi-optimal binwidths. The number of clusters in the data set is the largest determined number of modes over the set of quasi-optimal binwidths.	03-06-2014

Inge Neubueser, Hamburg DE

Patent application number	Description	Published
20100146710	Reductive Decoloration of Keratin-Containing Fibers - The invention relates to compositions comprising a combination of (a) at least one organic compound which carries at least one thiol group and at least one optionally derivatized carboxyl group, for example L-cysteine, and (b) at least one organic compound selected from the group which is formed from cyclic, organic carbonates, glycerol and its derivatives and C	06-17-2010

Inge Neubüser, Hamburg DE

Patent application number	Description	Published
20110048447	Method for Smoothing Fibers Containing Keratin - Method for smoothing fibers containing keratin, in particular human hair. Fibers are subjected to a thermal treatment and to a treatment with an agent containing at least one conditioning compound selected from cationic polymers, quaternary ammonium compounds, silicones and protein hydrolyzates. The invention also relates to the use of an agent containing at least one of the conditioning compounds concerned in said method for smoothing fibers containing keratin. The inventive method achieves an excellent, uniform smoothing of the fibers, which are also conditioned.	03-03-2011

Inge Neubüser, Hamburg DE

Patent application number	Description	Published
20110048447	Method for Smoothing Fibers Containing Keratin - Method for smoothing fibers containing keratin, in particular human hair. Fibers are subjected to a thermal treatment and to a treatment with an agent containing at least one conditioning compound selected from cationic polymers, quaternary ammonium compounds, silicones and protein hydrolyzates. The invention also relates to the use of an agent containing at least one of the conditioning compounds concerned in said method for smoothing fibers containing keratin. The inventive method achieves an excellent, uniform smoothing of the fibers, which are also conditioned.	03-03-2011
20110162670	Composition and Method for the Smoothing of Fibres Containing Keratin - The invention relates to a composition which is oxidatively effective on keratin-containing fibers, in particular human hair, and which, besides at least one oxidizing agent, comprises an active ingredient combination of (a) a selected cationic polymer, (b) at least one mono- or di(C.sub.8- to C.sub.30)-alkylammonium salt and (c) at least one quaternary ammonium compound which carries at least one selected group on the quaternized nitrogen atom, and to a method of reshaping keratin-containing fibers, in which this composition is used, and to the use of this composition for fixing in the course of hair reshaping. The reshaping is improved through these compositions and the fiber receives excellent care and structure retention.	07-07-2011

Inge Nilsson, Uddevalla SE

Patent application number	Description	Published
20100154358	METHOD AND ASSEMBLY FOR SEPARATING OPENING DEVICES SUPPLIED JOINTLY IN THE FORM OF A SHEET AND APPLIED INDIVIDUALLY TO RESPECTIVE PACKAGES OF POURABLE FOOD PRODUCTS - A method of separating opening devices supplied jointly in the form of a sheet and applied individually to respective packages of pourable food products involves feeding the sheet, which has a number of parallel rows of opening devices integral with one another, to a first station where a first row is detached from the rest of the sheet. The first row is fed to a second station where it is divided into individual opening devices, and a following second row of the sheet is fed to the first station as the preceding first row is being fed to the second station and/or is being at least partly divided.	06-24-2010
20110203223	PRESSURE DEVICE FOR EXERTING PRESSURE ON AN OPENING DEVICE FITTED TO A PACKAGE OF A FOOD PRODUCT POURABLE INTO A TUBE OF PACKAGING MATERIAL - A pressure device for exerting pressure on an opening device fitted to a package of a food product pourable into a tube of packaging material, the device having a first pressure member movable between a first work position, in which it presses a first area of the opening device against the package, and a first rest position, in which it is detached from the opening device; and a second pressure member movable between a second work position, in which it presses a second area of the opening device against the package, and a second rest position, in which it is detached from the opening device; the first and second area being crosswise to each other.	08-25-2011

Inge Norum, Hafrsfjord NO

Patent application number	Description	Published
20110196909	Node to Node Collaboration - Implementations of node to node collaboration are described. In one technique described herein, one or more secondary nodes coupled to a primary node are identified. In one possible implementation, the secondary nodes are coupled to the primary node via a peer to peer network. Resources associated with the one or more secondary nodes can be shared with the primary node to improve a performance of an oilfield services application being run at the primary node.	08-11-2011

Inge Ostergaard, Heggedal NO

Patent application number	Description	Published
20090048028	Sealing Element and a Coupling Device Provided with Such a Sealing Element - A sealing element including a tube-shaped body of metallic material and first and second male sealing members arranged at a respective end of the body. At least two intermediate members are arranged in series in the body between the first and second male sealing members. Each one of the intermediate members is compressible so as to be capable to store elastic energy when the body is subjected to axial compression and includes a protuberance arranged in the body and extending around the center axis of the body. A coupling device provided with such a sealing element.	02-19-2009

Inge Østergaard, Heggedal NO

Patent application number	Description	Published
20110155941	SEALING ELEMENT AND A COUPLING DEVICE AND A VALVE DEVICE PROVIDED WITH SUCH A SEALING ELEMENT - A sealing element that includes a hollow body of metallic material and first and second male sealing members formed at a respective end of the body. The respective male sealing member has an external spherical contact surface designed for mating with a corresponding internal conical contact surface of a female sealing member so as to form a fluid-tight seal between the male sealing member and the female sealing member when their contact surfaces are pressed against each other. Also, a coupling device and a valve device provided with the sealing element.	06-30-2011

Inge Peters, Voortkapel (westerlo) BE

Patent application number	Description	Published
20140219967	Poly (3-Hydroxybutyrate/3-Hydroxyvalerate) of Lowered Crystallinity for Use in Animal Feed - Animal feed conversion ratio can be increased and blood glucose levels can be decreased by feeding an efficacious amount of dispersible amorphous poly(3-hydroxybutyrate/3-hydroxyvalerate).	08-07-2014

Inge Raschke-Metzmann, Obrigheim DE

Patent application number	Description	Published
20090173435	Method and device for the production of photopolymerisable cylindrical jointless flexographic printing elements - Processes comprising providing a layer composite comprising a layer of photopolymerizable material and a removable substrate film disposed on one side of the layer of photopolymerizable material, wherein the photopolymerizable material comprises an elastomeric binder, an ethylenically unsaturated monomer and a photoinitiator; and (a) miter-cutting two edges of the layer composite to be joined, to form two miter-cut ends; (b) providing a hollow cylinder on a rotatably mounted support cylinder, wherein the hollow cylinder has an outer surface and is in a temporarily locked position relative to the support cylinder; (c) applying an adhesion-promoting layer to the outer surface of the hollow cylinder; (d) applying the layer composite to the hollow cylinder bearing the adhesive-promoting layer, wherein the layer composite is disposed on the hollow cylinder such that the removable substrate film faces away from the hollow cylinder and the two miter-cut ends lie substantially one on top of the other, but not overlapping; (e) removing the substrate film from the layer of photopolymerizable material to provide an exposed surface of the layer of photopolymerizable material; (f) contacting the exposed surface of the layer of photopolymerizable material with a rotating calender roll with heating to join the two miter-cut edges and form a processed hollow cylinder, wherein heating comprises a locally-acting heat source moved in an axial direction relative to the hollow cylinder along the entire width of the layer of photopolymerizable material such that the exposed surface is heated; and (g) removing the processed hollow cylinder from the support cylinder.	07-09-2009

Inge Ritzka, Eschweiler DE

Patent application number	Description	Published
20100171591	SYSTEM COMPRISING A TRANSPONDER, CONSUMER ITEM OR OTHER PRODUCT, AND METHOD FOR FITTING AN ITEM WITH A TRANSPONDER - The aim of the invention is to improve previously known systems and applications for protecting persons and goods. The aim is achieved by a method for protecting persons and goods and structurally delimiting closed areas by means of a transponder, e.g. an RFID chip, which is permanently or removably mounted on an item or a person and allows data on the item and the persons' status to be stored, means for recognizing the transponder and the transponder data that is stored using the transponder, means for storing reference data on the transponder data, and a central administration for comparing the transponder data and the reference data.	07-08-2010

Inge Rosquin, Koningshooikt BE

Patent application number	Description	Published
20090265817	T227-1 FLANKING SEQUENCE - A herbicide resistant transformed sugar beet that is detectable by the specific primers developed to match the DNA sequences that flank the left and/or right border region of the inserted transgenic DNA and the method of identifying primer pairs containing plant genomic DNA/plasmid DNA. More specifically, the present invention covers a specific glyphosate resistant sugar beet plant having an insertion of the transgenic material identified as the T227-1 event. The present invention additionally covers primer pairs: plant genomic DNA/Plasmid DNA that are herein identified. Additionally, these primer pairs for either the left or the right flanking regions make an event specific test for the T227-1 insert of transgenic material.	10-22-2009

Inge Schildermans, Gent BE

Patent application number	Description	Published
20100129682	METHOD TO PROVIDE COIL SHAVED METAL FIBERS - A method for providing coil shaved metal fibers according to the present invention comprises the steps of -providing a metal composite foil, the metal composite foil comprising oat least two metal layers (Lx) for being converted into metal fibers, each pair of adjacent metal layers are mutually separated by a sacrificial layer (Sy) provided from a sacrificial metal, each sacrificial layer (Sy) having a first and second surface, whereby for each sacrificial layer, the first surface contacts one of the pair of adjacent metal layers, the second surface is contacting the other of the pair of adjacent metal layers; -coiling said metal composite foil on a shaft thereby providing a metal coil having one free end surface; -rotating the metal coil and cutting the free end surface of the metal coil by means of a cutting tool, thereby providing a bundle of composite fibers; -removing the sacrificial metal of the sacrificial layers from the composite fibers thereby providing a bundle of metal fibers, each metal fiber being obtained from one of the metal layers (Lx).	05-27-2010
20100196218	FILTER MEDIUM - A filter medium (	08-05-2010
20120090469	MULTICARTRIDGE DIESEL SOOT PARTICULATE FILTER - The invention relates to a multicartridge diesel soot particulate filter (	04-19-2012

Inge Schildermans, Marke BE

Patent application number	Description	Published
20110107732	FILTER ELEMENTS - A filter element according to the invention comprises a filter volume having an inflow side and an outflow side defining an average flow direction. The filter volume has an axis substantially parallel to the average flow direction and further comprising a casing delimiting the outer boundary of the filter volume in the direction of the average flow path. The casing is gas impermeable in radial direction. The filter volume is filled with a filter material comprising fibers, a majority of the fibers at least partially encircle the axis.	05-12-2011
20110197555	FILTER ELEMENTS - A filter element (	08-18-2011
20110315341	REGENERATOR FOR A THERMAL CYCLE ENGINE - A regenerator (	12-29-2011
20120111199	DIESEL SOOT PARTICULATE FILTER CARTRIDGE - The invention relates to diesel soot particulate filter cartridge having a central filter cartridge axis. The filter cartridge has a radial flow. The filter cartridge comprises a porous structure. The porous structure is coiled around the central filter cartridge axis. The porous structure comprises non-sintered metal fibers, said fibers having a roughness being higher than 1.7. The invention further relates to a method of manufacturing a diesel soot particulate filter cartridge. Furthermore the invention relates to a multicartridge diesel soot particulate filter. The flow through the multicartridge diesel soot particulate filter is axial while the flow through the filter cartridges is radial.	05-10-2012
20130112611	DISC SHAPED FILTER ELEMENT - The invention relates to a disc shaped filter element for filtering a liquid such as a polymer. The filter element comprising—a hub, said hub defining a central opening therethrough,—an upper filter medium and a lower filter medium, said upper filter medium and said lower filter medium extending radially outwards from said hub. The upper filter medium and the lower filter medium comprise a layered structure comprising a first layer and a second layer. The first layer comprises a non-sintered metal fiber fleece and the second layer comprises a layer of non-sintered metal powder particles. The first layer and the second layer are sintered together.	05-09-2013
20140138368	SELECTIVE CATALYTIC REDUCTION TANK WITH HEATING ELEMENT - The invention describes a tank comprising a solution, dispersion or emulsion for selective catalytic reduction in combustion engines. The tank comprises an electrical resistive heating element immersed in the tank. The electrical resistive heating element comprises at least one heating cord. The heating cord comprises metal filaments. The metal filaments • comprise a copper layer or a layer in a copper alloy, and comprise a surrounding layer in stainless steel, • or comprise a steel layer, surrounded by a layer in copper or in a copper alloy, surrounded by a nickel, zinc or tin layer or a layer of alloys comprising such metals; • or comprise a layer of low carbon or high carbon steel, and comprise a surrounding nickel, zinc or tin layer or layer of alloys comprising such metals, and the heating cord comprises a polymer coating layer.	05-22-2014
20140153912	TANK WITH HEATING ELEMENT FOR SELECTIVE CATALYTIC REDUCTION - The invention describes a tank comprising a water or solvent based solution, dispersion or emulsion. The tank comprises an electrical resistance heating element immersed in the solution, dispersion or emulsion. The electrical heating element is provided in the tank with an electrical current. The electrical resistance heating elements comprises a textile fabric and at least one electrical heating wire. The electrical heating wire is fixed onto the textile fabric and the electrical heating wire comprises metal filaments or metal fibers.	06-05-2014
20150064606	ASSEMBLY OF A POROUS METAL DIFFUSION SUBSTRATE AND A POLYMERIC SEPARATOR MEMBRANE - The invention relates to an assembly of a porous metallic gas diffusion substrate and a polymeric separator membrane for use in an alkaline electrolyser or alkaline fuel cell. The polymeric separator membrane of the assembly comprises inorganic hydrophilic particulates dispersed in an organic polymeric binder. The polymeric separator membrane is gas tight when filled with electrolyte. The polymeric separator membrane is penetrating into at least a top portion of the porous metallic gas diffusion substrate. Also disclosed is a method to produce such an assembly via coating a paste on a porous metallic gas diffusion substrate.	03-05-2015
20150211153	METAL FIBRE WEB BASED FILTER - A filter membrane has at its flow in side a first metal fibre web, at least two metal fibre layers, and a fine and at least one coarser fibre layer. The fine fibre layer is located at the flow in side of the filter membrane and the at least one coarser fibre layer is located downstream of the fine fibre layer. The filter membrane has at its flow out side, a stack of one or more first two-dimensional metal structures with constant and regular openings. The filter membrane also has at least one set formed by a second metal fibre web and a stack of one or more second two-dimensional metal structure with constant and regular openings; the at least one set is provided in between the stack of one or more two-dimensional metal structures that are having constant and regular openings, and the first metal fibre web.	07-30-2015

Inge Sillaber, Munich DE

Patent application number	Description	Published
20080200411	MEANS AND METHODS FOR DIAGNOSING AND TREATING AFFECTIVE DISORDERS - Nucleic acid molecules encoding an ATP-gated ion channel P2X7R which contains a mutation or a deletion are disclosed. Polypeptides encoded by the nucleic acid molecules and antibodies that specifically are directed to these polypeptides are disclosed. Aptamers that specifically bind the nucleic acid molecules, and primers for selectively amplifying the nucleic acid molecules are provided, kits, compositions, particularly pharmaceutical and diagnostic compositions comprising the nucleic acid molecules, vectors, polypeptides, aptamers, antibodies and/or primers, are provided. Methods for diagnosing affective disorders associated with a non-functional P2X7R protein, an altered ATP-gating of the P2X7R protein, an over or underexpression of the P2X7R protein or associated with the presence of any one of the nucleic acid molecules or polypeptides encoded thereby are disclosed. Additionally, the present invention relates to uses and methods for treating affective disorders employing a functional or non-functional ATP-gated ion-channel P2X7R, such as treatment with modulators of P2X7R activity.	08-21-2008

Inge Tetens, Ballerup DK

Patent application number	Description	Published
20100261661	COMPOSITIONS AND METHODS FOR INCREASING THE SUPPRESSION OF HUNGER AND REDUCING THE DIGESTIBILITY OF NON-FAT ENERGY SATIETY - The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, over-weight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.	10-14-2010
20150320817	Compositions and Methods for Increasing the Suppression of Hunger and Reducing the Digestibility of Non-Fat Energy Satiety - The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed 10 mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.	11-12-2015

Inge Tinhofer, Berlin DE

Patent application number	Description	Published
20110178076	MEDICAL INTERVENTION IN HAEMATOLOGICAL CANCERS - The present invention relates to the medical and pharmaceutical use of substituted 1H-imidazo[4,5-c]quinolin-4-amines, in particular Imiquimod® and Gardiquimod®, alone or preferably in combination with Akt inhibitors, in particular with Akti1/2 and AktX, and most preferably with Akti1/2, in the treatment, prevention and/or amelioration of haematological cancers, in particular multiple myeloma disorders or B-cell disorders, and most particular in the therapy of multiple myeloma.	07-21-2011

Inge Van Bogaert, Laarne BE

Patent application number	Description	Published
20110136110	METHOD FOR THE PRODUCTION OF MEDIUM-CHAIN SOPHOROLIPIDS - The MFE2 gene of a microorganism capable of producing glycolipids, such as, but not limited to	06-09-2011
20120311741	SOPHOROLIPID TRANSPORTER PROTEIN - The invention relates to a transporter protein involved in the transport of sophorolipids. More specifically, it relates to a	12-06-2012

Inge Van De Wouw, Antwerp BE

Patent application number	Description	Published
20140036642	WAKE-UP APPLIANCE WITH SNOOZE FUNCTION - A wake-up appliance (	02-06-2014
20140354189	DIMMABLE LUMINARY FEATURING COLOUR CHANGE DURING DIMMING - A wake-up lamp system (	12-04-2014

Inge Van De Wouw, Tilburg NL

Patent application number	Description	Published
20150373806	LIGHTING DEVICE AND LIGHTING SYSTEM - A lighting device comprising a first light source issuing a first beam and a second light source issuing a second beam. Said first and said second light source are dimmable and together issue light with a total light flux. At a mutually equal light flux of the first and the second beam, the glare level of the second beam is lower than the glare level of the first beam. The lighting device further comprises at least one (programmed) controller which, during operation, moderates said dim levels such that in at least a range of the illumination level a ratio of the dim level of the second beam to the dim level of the first beam increases in a gradual manner with increasing total light flux.	12-24-2015

Inge Van Molle, Cambridge GB

Patent application number	Description	Published
20140356322	Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase - The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins that are degraded and/or otherwise inhibited by bifunctional compounds of the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand that binds to the ubiquitin ligase and on the other end a moiety that binds a target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds of the present invention, consistent with the degradation/inhibition of targeted polypeptides.	12-04-2014

Inge Vereycken, Deurne BE

Patent application number	Description	Published
20100035363	Homogeneous Time Resolved Fluorescence Based Test System for Paramyxoviridae - The present invention concerns a fluorescence resonance energy transfer based high throughput test system to measure the formation of the RSV F1 six-helix bundle. In a first embodiment the current invention relates to a homogeneous time resolved fluorescence-based test system comprising a first helical polypeptide consisting essentially of the sequence of IQN57 (SEQ ID NO: 1); a second helical polypeptide consisting essentially of the sequence of C45 (SEQ ID NO: 2) wherein said IQN57 is labeled with a light emitting fluorophore and said C45 is labeled with an ultra-violet excitable fluorophore.	02-11-2010
20100280268	HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM - The present invention concerns a fluorescence resonance energy transfer based high throughput test system to measure the formation of the HIV gp41 six-helix bundle. In a first embodiment the current invention relates to a homogeneous time resolved fluorescence-based test system comprising a first helical polypeptide consisting essentially of the sequence of IQN36 (SEQ ID NO:1); a second helical polypeptide consisting essentially of the sequence of C34 (SEQ ID NO: 2) wherein said IQN36 is labeled with a light emitting fluorophore and said C34 is labeled with an ultra-violet excitable fluorophore.	11-04-2010

Inge Vliegen, Holleweg BE

Patent application number	Description	Published
20110224208	NOVEL INHIBITORS OF FLAVIVIRUS REPLICATION - The present invention relates to a series of Isoquinolone derivatives which are suitable to treat infections with viruses belonging to the family of the Flaviviridae and more preferably infections with Hepatitis C virus (HCV). The present invention also relates to Isoquinolone compounds for use as a medicine for the prevention or treatment of viral infections, preferably infections with viruses belonging to the family of the Flaviviridae.	09-15-2011

Inge Welkenhuysen, Aalst BE

Patent application number	Description	Published
20100196646	DRY BLEND HAVING OXYGEN-SCAVENGING PROPERTIES, AND THE USE THEREOF FOR MAKING A MONOLAYER PACKAGING ARTICLE - For making a monolayer packaging article having O	08-05-2010